Clinical Trial Evaluating ITI-007 (Lumateperone) as a Monotherapy for the Treatment of Bipolar Depression

Clinical Site, Little Rock

Clinical Site, Rogers

Clinical Site, Cerritos

Clinical Site, Culver City

Clinical Site, Garden Grove

Clinical Site, Lemon Grove

Clinical Site, National City

Clinical Site, Oakland

Clinical Site, Oceanside

Clinical Site, Orange

Clinical Site, Pico Rivera

Clinical Site, Riverside

Clinical Site, San Diego

Clinical Site, San Marcos

Clinical Site, Santa Rosa

Clinical Site, Colorado Springs

Clinical Site, Bradenton

Clinical Site, Fort Myers

Clinical Site, Jacksonville

Clinical Site, Lauderhill

Clinical Site, Miami

Clinical Site, North Miami

Clinical Site, Orlando

Clinical Site, Atlanta

Clinical Site, Chicago

Clinical Site, Hoffman Estates

Clinical Site, Lake Charles

Clinical Site, Baltimore

Clinical Site, Boston

Clinical Site, O'Fallon

Clinical Site, St Louis

Clinical Site, Las Vegas

Clinical Site, Berlin

Clinical Site, Cherry Hill

Clinical Site, Marlton

Clinical Site, Toms River

Clinical Site, Brooklyn

Clinical Site, Cedarhurst

Clinical Site, New York

Clinical Site, Rochester

Clinical Site, Staten Island

Clinical Site, Cincinnati

Clinical Site, Cleveland

Clinical Site, Dayton

Clinical Site, Garfield Heights

Clinical Site, Oklahoma City

Clinical Site, Allentown

Clinical Site, Norristown

Clinical Site, Philadelphia

Clinical Site, Memphis

Clinical Site, Austin

Clinical Site, Dallas

Clinical Site, Houston

Clinical Site, Petersburg

Clinical Site, Everett